Results 91 to 100 of about 638,455 (170)
INtraVESical immunoTherapy (INVEST) prior to radical cystectomy for bladder cancer: trial protocol
BJU International, Volume 138, Issue 4, Page 607-619, October 2026.Background High‐risk non‐muscle‐invasive bladder cancer (HRNMIBC) has a variable prognosis, managed predominantly by local surgical resection and intravesical Bacillus Calmette–Guérin (BCG), or radical cystectomy (RC). Current treatments are poorly tolerated, have supply limitations and often fail to control the disease.
Ruby Lister‐Whelan +13 more
wiley +1 more source
Characteristics of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
, 2016 Characteristics of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Jayeun Kim (3344228) +9 more
core +1 more source
Contact Dermatitis, Volume 95, Issue 4, Page 349-357, October 2026.ABSTRACT Drug hypersensitivity reactions (DHRs) are common in children and are diagnostically challenging, with cutaneous manifestations being the most common presentation. Patch testing (PT) is a well‐established tool for investigating delayed T‐cell‐mediated reactions and is widely used in patients with contact dermatitis.
Gabriele Simonetti +7 more
wiley +1 more source
Toxic epidermal necrolysis: A review
Journal of the American Academy of Dermatology, 1991 This article reviews the many facets of toxic epidermal necrolysis. Emphasis is placed on the importance of early diagnosis, burn unit placement, supportive care, and avoidance of systemic steroids. Discussion also includes other therapeutic options and the pathophysiology of the disease.
From the College of Pharmacy, the Division of Dermatology and Cutaneous Surgery ( host institution ) +4 more
openaire +3 more sources
Internal Medicine Journal, Volume 56, Issue 10, Page 1765-1774, October 2026.Abstract Background Pharmacogenomic‐guided medication management optimises drug therapy to enhance patient outcomes. Despite clinical utility, implementation in Australia remains limited, partly due to the lack of clear and consistent guidance. Aim This study evaluated the presence and consistency of pharmacogenomic testing indication categories and ...
Ruby Soueid +4 more
wiley +1 more source
Acute epidermal necrolysis or Lyell syndrome.
, 1987 Acute epidermal necrolysis may be caused by staphylococcal toxins (staphylococcal scalded skin syndrome and toxic shock syndrome) or may be related to usually drug-induced hyper-sensitivity mechanisms (toxic epidermal necrolysis).
Sluysmans, Thierry +2 more
core
Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis from 2010 to 2013 in Korea.
, 2016 Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis from 2010 to 2013 in Korea.
Jayeun Kim (3344228) +9 more
core +1 more source
, 2020 Supplementary materials for JAAD-D-20-01192R2 Treating toxic epidermal necrolysis with systemic immunomodulating therapies: a systematic review and network meta ...
Tu, Y (via Mendeley Data), Tu, Yu-Kang
core +1 more source
, 2016 Characteristics of the mortality cases in 2011 from Stevens-Johnson syndrome and toxic epidermal necrolysis.
Jayeun Kim (3344228) +9 more
core +1 more source